REYON Pharmaceutical Co., Ltd.
102460.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$188.55B
Close$
Share Statistics
| Market cap | $188.55 Billion |
|---|---|
| Enterprise Value | $398.89 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1604.66 |
| Beta | 0.39 |
| Outstanding Shares | 18,341,000 |
Return
| Return on Equity | -17.67% |
|---|---|
| Return on Assets | -7.75% |
| Return on Invested Capital | -16.56% |
Valuation & Multiples
| P/E Ratio | -5.5 |
|---|---|
| PEG | 11.4 |
| Price to Sales | 1.32 |
| Price to Book Ratio | 0.97 |
| Enterprise Value to Revenue | 2.78 |
| Enterprise Value to EBIT | -8.42 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0.54 |
| Debt to Equity | 1.12 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About REYON Pharmaceutical Co., Ltd.
457 employees
CEO: Soon-Ock Jung Operating both domestically in South Korea and across international markets, REYON Pharmaceutical Co., Ltd. specializes in the production and distribution of pharmaceutical products and active pharmaceutical ingredients (APIs). The compa...